ACHIEVE LIFE SCIENCES, INC. — Director's Dealing 2012

Jun 4, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ONCOGENEX PHARMACEUTICALS, INC. (OGXI)
CIK: 0000949858
Period of Report: 2012-05-31

Reporting Person: PARKER H STEWART (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-05-31	Stock Option (right to buy)	$12.56	A	4000	Acquired	2022-05-31	Common (4000)	Direct
2012-05-31	Restricted Stock Units	$	A	2000	Acquired		Common (2000)	Direct

Footnotes

F1: The options vest 100% on the earlier of May 31, 2013 or the date immediately prior to the issuer's next annual meeting of stockholders.

F2: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F3: The restricted stock units vest 100% on the earlier of the first anniversary of the grant date or the date immediately prior to the issuer's next annual meeting of stockholders.

F4: The restricted stock units expire 30 days from the earlier of the first anniversary of the grant date or the date of the issuer's next annual meeting of stockholders.